B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

(2010) Ulf Klein et al.   CANCER CELL

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine

(2010) A E Foster et al.   LEUKEMIA

Side population and cancer stem cells: Therapeutic implications

(2009) Lidia Moserle et al.   CANCER LETTERS

ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells

(2009) Arcadi I. Svirnovski et al.   Hematology

Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles

(2009) M Plander et al.   LEUKEMIA

Further progress in CLL therapy

(2008) E. Montserrat   BLOOD

Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

(2008) W. Matsui et al.   CANCER RESEARCH

Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation

(2008) P. Ghia et al.   JOURNAL OF INTERNAL MEDICINE

Chronic lymphocytic leukaemia

(2008) G Dighiero et al.   LANCET

Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities

(2008) S Struski et al.   LEUKEMIA

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

(2008) J E Castro et al.   LEUKEMIA

Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides

(2008) C. de Wolf et al.   MOLECULAR CANCER THERAPEUTICS

Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties

(2008) Vera Levina et al.   PLoS One